The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / EULAR 2014: Collaboration Among Rheumatology Groups Expected to Build

EULAR 2014: Collaboration Among Rheumatology Groups Expected to Build

September 1, 2014 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
  • EULAR 2014: Ultrasound Use Important for Rheumatology
  • EULAR 2014: Biosimilar Drug Production Raises Concerns
Explore This Issue
September 2014
Also By This Author
  • COVID-19 Risks & Treatment for Patients with Rheumatic Disease

PARIS, FRANCE—The amount of collaboration between the American College of Rheumatology and the European League Against Rheumatism, as well as other international groups, is likely to continue to grow when it comes to creating criteria and response sets, and patient management guidelines, said Kenneth Saag, MD, MSc, professor of medicine at the University of Alabama at Birmingham, a member of the ACR Board of Directors, and a leader in the writing of the ACR’s most recent RA management guidelines.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

There are hurdles to overcome, however, not the least of which is the different healthcare systems involved, Dr. Saag said in a session on RA management guidelines throughout the world at the Annual European Congress of Rheumatology (EULAR 2014) in June. His talk also delved into the philosophy behind guideline creation and touched on future additions to ACR guidelines.

As for international cooperation, ACR and EULAR have already collaborated on remission criteria, and they jointly developed classification criteria on polymyalgia rheumatica (PMR), which were presented this year at another EULAR session.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Saag said the presentation of the PMR guidelines made it a “pivotal meeting” for joint guideline efforts.

Dr. Smolen
Dr. Smolen

“It’s also important to highlight that the joint activity between ACR and EULAR along classification response criteria has been ongoing quite successfully for many years,” he said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

He said he’d like more collaboration not just with EULAR but other large, international organizations, too. But with such factors as “institutional politics,” it can be a “complicated” endeavor.

“Trying to just maintain the flow with EULAR is challenging for both sides—to deal with financial models, to deal with conflict issues, to deal with different healthcare systems,” he said. “And that’s where I think it’s been a little more challenging for guidelines. But it doesn’t mean we can’t do it, and in fact we have momentum. This is a positive sign.”

Dr. Saag
Dr. Saag

Early Days

Josef Smolen, MD, chair of the Division of Rheumatology at the Medical University of Vienna, said it was worth remembering that efforts at collaborating are only 10 years old. He said it was 2003 when he suggested that the ACR and EULAR start working together.

“It took a few years to get it off the ground,” he said. “And I find it fantastic that we already have so many common activities. And not only activities, but results.”

He acknowledged the difficulties.

“We in Europe cannot understand that something that [we’ve had for] 120 years is only being debated in the United States,” he said. “So there are these differences in healthcare systems.”

Constant Change

In his remarks about the ACR guidelines, Dr. Saag described a constant state of reexamination—evidence changes or emerges and methods of creating the guidelines change, leading to adaptations that are always attempting to keep pace with the medicine.

Pages: 1 2 3 | Single Page

Filed Under: Biologics & Biosimilars, Conditions, DMARDs & Immunosuppressives, Drug Updates, Guidelines, Meeting Reports, Safety Tagged With: AC&R, American College of Rheumatology, Biologics, collaboration, Collins, drug, EULAR, Glucocorticoids, International, patient care, Polymyalgia Rheumatica, rheumatology, Safety, TofacitinibIssue: September 2014

You Might Also Like:
  • EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
  • EULAR 2014: Ultrasound Use Important for Rheumatology
  • EULAR 2014: Biosimilar Drug Production Raises Concerns
  • EULAR 2014: Non-Tumor Necrosis Factor Biologics Update

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.